Skip to content
MedsAcross

Alternatives

Alternatives to Doxorubicin Hydrochloride Liposome 50 mg/25 mL liposomal injectable suspension

4 other presentations of Doxorubicin 50 mg/25 mL liposomal injectable suspension

There are 4 alternatives to this medicine in the catalogue: the same active ingredient (Doxorubicin), strength (50 mg/25 mL) and dosage form (liposomal injectable suspension) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Doxorubicin Hydrochloride Liposome 50 mg/25 mL liposomal injectable suspensionThis pageIntravenousSagent PharmaceuticalsUS FDA1 vial of 25 mLCold chainOn request—Available on request
Doxorubicin 50 mg/25 mL liposomal injectable suspensionIntravenous—US FDA1 vial of 25 mL, 1 vial of 25 mLCold chainOn request—Available on request
Doxil 50 mg/25 mL liposomal injectable suspensionIntravenousBaxter HealthcareUS FDA1 vial of 25 mLCold chainOn request—Available on request
Doxil 50 mg/25 mL liposomal injectable suspensionIntravitrealBaxter HealthcareUS FDA1 vial of 25 mLCold chainOn request—Available on request
Doxorubicin 50 mg/25 mL liposomal injectable suspensionIntravitreal—US FDA1 vial of 25 mLCold chainOn request—Available on request

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Doxorubicin Hydrochloride Liposome 50 mg/25 mL liposomal injectable suspension

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.